TITLE

Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario

AUTHOR(S)
Mamdani, Muhammad; Warren, Leanne; Kopp, Alex; Paterson, J. Michael; Laupacis, Andreas; Bassett, Ken; Anderson, Geoffrey M.
PUB. DATE
December 2006
SOURCE
CMAJ: Canadian Medical Association Journal;12/5/2006, Vol. 175 Issue 12, p1535
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Population rates of upper gastrointestinal (GI) hemorrhage have been observed to increase with the introduction and rapid uptake of selective cyclooxygenase-2 (COX-2) inhibitors. Changes in COX-2 inhibitor use and upper GI bleeding rates in regions with relatively restrictive drug policies (e.g., British Columbia) have not been compared with changes in regions with relatively less restrictive drug policies (e.g., Ontario). Methods: We collected administrative data for about 1.4 million people aged 66 years and older in British Columbia and Ontario for the period January 1996 to November 2002. We examined temporal changes in the prevalence of NSAID use and admissions to hospital because of upper GI hemorrhage in both provinces using cross-sectional time series analysis. Results: During the period studied, the prevalence of NSAID use in British Columbia's population of older people increased by 25% (from 8.7% to 10.9%; p < 0.01), as compared with a 51% increase in Ontario (from 10.9% to 16.5%; p < 0.01). Hospital admissions because of upper GI hemorrhage increased significantly in Ontario by about 16% on average, or about 2 admissions per 10 000 elderly people, above expected values (p < 0.01). A similar increase was not observed in British Columbia. Interpretation: More restrictive drug coverage policies, although limiting access to drugs and their potential benefits, may protect the population from adverse drug effects.
ACCESSION #
23229451

 

Related Articles

  • Increase in Nonfatal Digestive Perforations and Haemorrhages Following Introduction of Selective NSAIDs: A Public Health Concern. Barnard, Louise; Lavoie, Dominic; Lajeunesse, Nancy // Drug Safety;2006, Vol. 29 Issue 7, p613 

    BACKGROUND AND OBJECTIVE: This article documents the impact of the introduction of selective NSAIDs on overall prescription patterns of NSAIDs and associated gastroprotective agents (GPAs), and on the rate of nonfatal digestive perforations and haemorrhages. METHODS: A retrospective, closed...

  • COX-2 inhibitors: lower GI bleeding risk but population risk increased?  // Reactions Weekly;5/22/2004, Issue 1002, p3 

    Discusses research being done on the risk of gastrointestinal bleeding associated with the introduction of cyclo-oxygenase 2 inhibitors. Reference to a study by M. Mamdani et al, published in the May 2004 issue of the "British Medical Journal"; Increase in the prevalence of non-steroidal...

  • Gastrointestinal bleeding after the introduction of COX 2 inhibitors:ecological study. Mamdani, Muhammad; Juurlink, David N.; Kopp, Alex; Naglie, Gary; Austin, Peter C.; Laupacis, Andreas // BMJ: British Medical Journal (International Edition);6/12/2004, Vol. 328 Issue 7453, p1415 

    Presents an ecological study to examine temporal changes in the use of nonsteroidal anti-inflammatory drugs and upper gastrointestinal hemorrhage hospitalization rates among a population of older people after the introduction of cyclo-oxygenase-2 (COX 2) inhibitors. Report that the increased...

  • Review: Misoprostol or COX-2-specific or selective NSAIDs reduce gastrointestinal complications and symptomatic ulcers.  // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p75 

    This article presents a study, which reports that Misoprostol or COX-2-specific or selective non-steroidal anti-inflammatory drugs (NSAID) reduce gastrointestinal (GI) complications and symptomatic ulcers. The study method consisted of randomized controlled trials for 21 days in duration...

  • NON-STEROIDAL ANTI-INFLAMMATORY DRUGS.  // Current Medical Literature: Rheumatology;2004, Vol. 23 Issue 1, p13 

    Presents citations and clinicians' notes on studies on non-steroidal anti-inflammatory drugs. "Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs," by T.M. MacDonald, et al;...

  • An overview of gastropathy induced by nonsteroidal anti-inflammatory drugs. Schellack, Natalie // South African Pharmaceutical Journal;2012, Vol. 79 Issue 4, p12 

    Nonsteroidal anti-inflammatory drugs (NSAIDs) constitute a well-known group of drugs that are most widely used for a variety of inflammatory conditions and pain. However, their gastrointestinal side-effects, i.e. ulcers and gastrointestinal bleeding, hamper their usefulness in many clinical...

  • THE EFFECT OF CYCLOOXYGENASE-2 INHIBITION ON ANALGESIA AND SPINAL FUSION. Reuben, Scott S.; Ekman, Evan F. // Journal of Bone & Joint Surgery, American Volume;Mar2005, Vol. 87-A Issue 3, p536 

    THIS ARTICLE HAS BEEN RETRACTED BY THE PUBLISHER. http://www.ejbjs.org/cgi/content/full/91/4/965 Background: Cyclooxygenase (COX)-2-specific inhibitors demonstrate analgesic efficacy comparable with that of conventional nonsteroidal anti-inflammatory drugs but are associated with reduced...

  • Celecoxib Enhances the Anti-inflammatory Effects of Farnesylthiosalicylic Acid on T Cells Independent of Prostaglandin E Production. Mor, Adam; Aizman, Elizabeta; Kloog, Yoel // Inflammation;Oct2012, Vol. 35 Issue 5, p1706 

    Celecoxib (Celebrex), a non-steroidal anti-inflammatory drug and selective cyclooxygenase-2 inhibitor, is widely used to treat arthritis and other inflammatory disorders. Awareness of its anti-proliferative properties has prompted another indication for its use, in preventing colon polyps in...

  • COX-2s and NSAIDs: similar risk of GI haemorrhage in warfarin users.  // Reactions Weekly;3/5/2005, Issue 1041, p4 

    Discusses research being done on the relationship of warfarin, COX-2 inhibitors and nonselective non-steroidal anti-inflammatory drugs (NSAID) with the risk of gastrointestinal (GI) haemorrhage. Reference to a study by M. Battistella et al published in the January 24, 2005 issue of "Archives of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics